跳至主要内容
临床试验/NCT01278472
NCT01278472Unknown不适用

Cosmesis and Body Image After Single Port Laparoscopic or Conventional Laparoscopic Cholecystectomy: A Double Blinded Randomised Controlled Trial

University of Zurich2 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
110
试验地点
2
主要终点
Cosmetic Score

研究概览

简要总结

Laparoscopic Cholecystectomy (LC) is the treatment of choice for symptomatic gallstone disease. Single-port access cholecystectomy (SL) has been recently introduced using only one, trans-umbilical placed port. The method has been denominated as ''scarless.'' However, it is unknown whether SL significantly improves body and cosmesis images as well as the quality of life (QoL), reported directly by the patients. Furthermore SL promises to reduce postoperative pain and to be cost-effective due a faster postoperative recovery.

The aim of this Double Blind Randomized Controlled Trial (RCT) is to demonstrate whether SL is superior to LC in improving patients', body and cosmesis images as well as QoL and to analyse cost-efficiency.

Based on the sample size calculations, a total of 110 patients will be randomised to either LC or SL. The primary endpoint will be the cosmetic score. Costs, pain, time to convalescence, quality of life and complications and will also be compared as secondary endpoints.

This study will provide evidence-based patient-oriented information regarding the SL procedure and its further use.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients above 18 years of age for elective cholecystectomy
  • Written informed consent from the subject
  • INR < 1.4, platelet count > 50'000/mcl

排除标准

  • Women in pregnancy
  • Contraindications on ethical grounds
  • Severe coagulopathy (platelet < 50'000/mcl, double medication on platelet antagonists (Plavix and Aspirin), INR > 1.4
  • liver cirrhosis
  • Enrolment of the investigator, his/her family members, employees and other dependent persons

结局指标

主要结局

Cosmetic Score

时间窗: 6 weeks postoperatively

validated score where the minimum is 3 and the maximum 24 points. A higher score signifies a greater satisfaction of the physical appearance of the scar

次要结局

  • Body Image(6 weeks postoperatively)
  • Pain(up to 6 weeks postoperatively)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验